25-11-2025 12:55 via drugs.com

GLP-1 Weight-Loss Drug in Pill Form Shows Promise in Trial

TUESDAY, Nov. 25, 2025— New clinical trial results bode well for what could be the first GLP-1 weight loss drug taken as a pill, not by injection.The daily pill, orforglipron, is currently under investigation by drugmaker Eli Lilly, which funded t...
Read more »

Pharmaceutical news



RSNA: Deep Learning Model Has Identified Imaging Biomarker for Chronic Stress
Cardiac Screening Tools Fail to Identify Many Patients at Risk
Gas-Permeable Lenses Beneficial After Congenital Glaucoma Surgery
Discontinuing GLP-1 Receptor Agonist Use Before Pregnancy Tied to Risk for Adverse Outcomes
Long-Term Exposure to Black Carbon Linked to Risk for Asthma, COPD
Myelodysplastic Syndromes Tied to Incident Cardiovascular Disease
Prenatal Exposure to Metal Mixture Linked to Childhood Allergic Symptoms
Chronic Pruritus Prevalent Among Older Adults
Cannabis Cuts Alcohol-Associated Liver Disease in Patients With Alcohol Use Disorder
Investing in Nurses Reduces Physician Burnout
Most Preschoolers Aren’t Getting Enough Daily Exercise, Study Finds
How to Enjoy Holiday Meals Without Feeling Stuffed All Day
Pill Form of Semaglutide Fails to Slow Alzheimer's in Large Trial
New Female Crash Dummy Aims to Make Cars Safer for Women
Desktop versie